<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82933">
  <stage>Registered</stage>
  <submitdate>26/06/2008</submitdate>
  <approvaldate>30/09/2008</approvaldate>
  <actrnumber>ACTRN12608000499381</actrnumber>
  <trial_identification>
    <studytitle>Chlamydia Prevalence and Testing Project - a randomised controlled trial</studytitle>
    <scientifictitle>Chlamydia prevalence and testing program targetting women aged 16 to 24 years in general practice</scientifictitle>
    <utrn />
    <trialacronym>CLASP</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Genital chlamydia infection</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Sexually transmitted infections</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The randomisation unit is general practitioner (GP) clinic.
Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year.  The intervention will be in place for 6 months.
GPs will be expected to conduct chlamydia screening during a routine consultation with an eligible patient. Screening involves requesting a chlamydia test for the patient. It should take a couple of minutes to discuss with the patient during the consultation</interventions>
    <comparator>Control group: Will receive no payment.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The proportion of women aged 16 to 24 years consulting each general practice who have had at least one chlamydia test during the 6 months.</outcome>
      <timepoint>6 months after the intervention commencement</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The prevalence of chlamydia among those tested at 6 months after intervention commencement.</outcome>
      <timepoint>6 months after intervention commencement</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>&gt;250 women aged 16-24 years attending the GP clinic in the past year.
Minimum of 2 full time equivalent (EFT) GPs per clinic.
An electronic medical records database.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Clinics will be excluded from the project if they do not see more than 250 women aged 16 to 24 years per year.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>GP clinics will be randomly allocated to the treatment following their enrolment in the study and obtaining informed consent. Block randomisation in blocks was used to allocate the intervention.  This was done by a statistician independently of the research assistants obtaining informed consent from the clinics.</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/05/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>12</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Melbourne</primarysponsorname>
    <primarysponsoraddress>University of Melbourne
Level 2, 723 Swanston St
Carlton VIC 3053</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Department of Human Services</fundingname>
      <fundingaddress>PUblic Health Branch
50 Lonsdale St
Melbourne VIC 3001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine whether a $5 incentive payment will lead to increased chlamydia testing rates by general practitioners.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Melbourne</ethicname>
      <ethicaddress>University of Melbourne
Level 2, 723 Swanston St
Carlton VIC 3053</ethicaddress>
      <ethicapprovaldate>20/01/2006</ethicapprovaldate>
      <hrec>050747</hrec>
      <ethicsubmitdate>1/12/2005</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jane Hocking</name>
      <address>Key Centre for Women's Health in Society
University of Melbourne
level 2, 723 Swanston St
Carlton VIC 3053</address>
      <phone>03-83440762</phone>
      <fax />
      <email>jhocking@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Jade Bilardi</name>
      <address>580 Swanston St
Carlton Sth VIC 3053</address>
      <phone>03 -93416263</phone>
      <fax />
      <email>jbilardi@mshc.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jane Hocking</name>
      <address>University of Melbourne
Key Centre for Women's Health in Society
Level 2, 723 Swanston St
Carlton VIC 3053</address>
      <phone>03-8344 0762</phone>
      <fax />
      <email>jhocking@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>